Follow-On Cancer Drugs Target Earlier Stages Than Initial Drugs: Implications Of The IRA Tomas J. Philipson, Qi Zhao, Deyu Zhang, Kira Fujibayashi, and Heather Johnson

https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2025.00627?utm_campaign=december%202025%20issue&utm_medium=email&_hsenc=p2ANqtz-_CvJwUPCFQ0zWGdFYXuoXvVgPxb8NMtNir_JweN3IeixMA6ZdX-OmtZMO_QO65LrF7Uf8m98vYFfwcVnXtUe-o53azCQ&_hsmi=393186972&utm_source=hasu